GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Novadaq Technologies Inc (NAS:NVDQ) » Definitions » Net Cash per Share

Novadaq Technologies (Novadaq Technologies) Net Cash per Share : $0.22 (As of Jun. 2017)


View and export this data going back to 2012. Start your Free Trial

What is Novadaq Technologies Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Novadaq Technologies's Net Cash per Share for the quarter that ended in Jun. 2017 was $0.22.

The historical rank and industry rank for Novadaq Technologies's Net Cash per Share or its related term are showing as below:

NVDQ's Price-to-Net-Cash is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 7.25
* Ranked among companies with meaningful Price-to-Net-Cash only.

Novadaq Technologies Net Cash per Share Historical Data

The historical data trend for Novadaq Technologies's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novadaq Technologies Net Cash per Share Chart

Novadaq Technologies Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 2.64 1.93 1.31 0.65

Novadaq Technologies Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 0.90 0.65 0.40 0.22

Competitive Comparison of Novadaq Technologies's Net Cash per Share

For the Diagnostics & Research subindustry, Novadaq Technologies's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novadaq Technologies's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Novadaq Technologies's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Novadaq Technologies's Price-to-Net-Cash falls into.



Novadaq Technologies Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Novadaq Technologies's Net Cash per Share for the fiscal year that ended in Dec. 2016 is calculated as

Net Cash per Share (A: Dec. 2016 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(62.383-24.92-0)/57.4451
=0.65

Novadaq Technologies's Net Cash per Share for the quarter that ended in Jun. 2017 is calculated as

Net Cash per Share (Q: Jun. 2017 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(49.59-37.071-0)/57.822
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novadaq Technologies  (NAS:NVDQ) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Novadaq Technologies Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Novadaq Technologies's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Novadaq Technologies (Novadaq Technologies) Business Description

Traded in Other Exchanges
N/A
Address
Novadaq Technologies Inc was incorporated under the Canada Business Corporations Act on April 14, 2000. The Company develops and commercializes medical imaging and therapeutic devices for use in the operating room. It's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company's business activities are conducted through one segment, which consists of medical devices. Its product includes, SPY Elite, PINPOINT Endoscopic Fluorescence Imaging, FIREFLY System for Robotic Surgery, LUNA Fluorescence Angiography and CO2 HEART LASER System. The SPY Imaging System provides clinically relevant information that empowers surgeons to make informed critical decisions in the operating room. PINPOINT Endoscopic Fluorescence Imaging System combines all of the fluorescence imaging capabilities of SPY Imaging with the HD visible light imaging capabilities of a traditional endoscopic imaging system. FIREFLY system enables surgeons performing robotic surgery to benefit from fluorescence imaging, with initial use in applications ranging from urology to gynecology. LUNA fluorescence angiography enables clinicians to visually assess tissue perfusion in diabetic foot ulcers and non-healing wounds. The CO2 HEART LASER System consists of: the CO2 HEART LASER mobile console and the CO2 HEART LASER disposable hand pieces. The Company's intellectual property consists of 49 patent families representing 128 granted or allowed patents and 90 pending applications in various stages of review and prosecution.

Novadaq Technologies (Novadaq Technologies) Headlines

From GuruFocus

Prem Watsa Increases Novadaq Technologies Ownership to 6.6 Pct

By Holly LaFon Holly LaFon 02-14-2013

Baron Funds Comments on Novadaq Technologies

By Holly LaFon Holly LaFon 01-20-2017